Apologies, when I said ResAppDx I meant the algorithm (I've done this in the past as well).
"ResApp has developed smartphone-based machine learning algorithms that have been found in a prospective clinical study to accurately identify acute exacerbations in patients with asthma or COPD. ResApp also has ongoing clinical programs investigating the use of these techniques to measure exacerbation severity and lung function."
Ann: Proposed issue of Securities - RSH, page-189
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 122878 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 30000 | 1 |
View Market Depth
| Last trade - 10.54am 14/10/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable